medRxivGenetic & Genomic MedicinePreprint
Guidance for clinical variant classification in genes for spliceosomal small nuclear RNAs
Elston N. D’SouzaiD, Alexander J. M. BlakesiD, Robin PaluchiD, Siddharth BankaiD, Maya ChopraiD, Alison J. CoffeyiD, Christel DepienneiD, Wojciech P. GalejiD, Sylvie MazoyeriD, Caroline NavaiD, Anne O’Donnell‐LuriaiD, Jillian O'Toole, Pia Riestra Crespo, Carlo RivoltaiD, Stephan J SandersiD, Nicola WhiffiniD
Abstract
BackgroundSmall nuclear RNAs (snRNAs) are RNA components of the major and minor spliceosomes that play a core role in splice-site recognition and control of the splicing process. Variants in genes that produce snRNAs are increasingly recognised as major contributors to rare disorders, including neurodevelopmental disorders (NDD) and retinal dystrophies (collectively termed RNUopathies, a subset of spliceosomopathies). Clinical interpretation of variants in snRNAs is, however, challenging and existing guidance to support clinical variant classification does not adequately capture the unique features of snRNAs that necessitate a bespoke approach. MethodsWe quantified the elevated background mutation rate in snRNA genes using de novo variants from 12,007 trios and assessed mutation density in 76,215 genome sequenced individuals in gnomAD. We convened a panel of clinical, research, and industry scientists with wide-ranging expertise in clinical variant interpretation and classification and expert knowledge in snRNA genes to draft and refine a guidance document. ResultsWe detail important considerations for variant classification in snRNA genes. These include: the difficulties of variant identification which requires genome or targeted sequencing approaches, the large number of gene paralogs with high sequence identity that complicate read mapping and variant calling, and historical inaccuracies in snRNA gene annotation. Further we show a [~]50-fold increase in de novo mutation rate in snRNA genes compared to intergenic sequence and discuss the implications of this for variant classification. We provide a set of specific recommendations for classifying variants in snRNA genes. Finally, we introduce RNUdb, an interactive web-based tool to support snRNA variant annotation and classification. ConclusionsWe provide the first guidance for clinical variant classification in snRNA genes and anticipate that this will support routine screening and analysis of snRNA genes in clinical genetic testing.
- organism: human
- assay: whole-genome sequencing
- research focus: variant calling
- research focus: database / resource
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dominant variants in major spliceosome U4 and U5 small nuclear RNA genes cause neurodevelopmental disorders through splicing disruption
Caroline Nava, Benjamin Cogné, … Radu Harbuz·Nature GeneticsPeer-reviewed·May 16, 2025
- Analysis of spliceosome-related coding and noncoding genes and pseudogenes reveals novel candidates
Olfa Messaoud, Stephanie P. DiTroia, … Anne O’Donnell‐Luria·medRxiv·Aug 10, 2026
- Characterization of snRNA-related neurodevelopmental disorders through the Spanish Undiagnosed Rare Disease Programs
Marta Sevilla Porras, Esther Nieto-Molina, … Mireia del Toro·medRxiv·Sep 16, 2025
- De novo variants in the non-coding spliceosomal snRNA gene RNU4-2 are a frequent cause of syndromic neurodevelopmental disorders
Yuyang Chen, Ruebena Dawes, … David H. Viskochil·NaturePeer-reviewed·Jul 11, 2024
- Systematic analysis of snRNA genes reveals frequent RNU2-2 variants in dominant and recessive developmental and epileptic encephalopathies
Elsa Leitão, Amandine Santini, … Johanna Herwig·Nature GeneticsPeer-reviewed·Mar 30, 2026
- Transcriptome-wide outlier approach identifies individuals with minor spliceopathies
Taylor M. Maurer, Rodrigo Mendez, … Vijay S Ganesh·The American Journal of Human GeneticsPeer-reviewed·Sep 19, 2025